These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 24075603)

  • 1. Long-term effects of asenapine or olanzapine in patients with persistent negative symptoms of schizophrenia: a pooled analysis.
    Potkin SG; Phiri P; Szegedi A; Zhao J; Alphs L; Cazorla P
    Schizophr Res; 2013 Nov; 150(2-3):442-9. PubMed ID: 24075603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asenapine versus olanzapine in people with persistent negative symptoms of schizophrenia.
    Buchanan RW; Panagides J; Zhao J; Phiri P; den Hollander W; Ha X; Kouassi A; Alphs L; Schooler N; Szegedi A; Cazorla P
    J Clin Psychopharmacol; 2012 Feb; 32(1):36-45. PubMed ID: 22198451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early improvement as a predictor of treatment response and remission in patients with schizophrenia: a pooled, post-hoc analysis from the asenapine development program.
    Leucht S; Zhao J
    J Psychopharmacol; 2014 Apr; 28(4):387-94. PubMed ID: 24429222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early improvement as a predictor of acute treatment outcome in manic or mixed episodes in bipolar-1 disorder: a pooled, post hoc analysis from the asenapine development program.
    Szegedi A; Zhao J; McIntyre RS
    J Affect Disord; 2013 Sep; 150(3):745-52. PubMed ID: 23473546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of depressive symptoms in schizophrenia.
    Castle DJ; Slott Jensen JK
    Clin Schizophr Relat Psychoses; 2015 Apr; 9(1):13-20. PubMed ID: 25367164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asenapine for the treatment of adults with an acute exacerbation of schizophrenia: results from a randomized, double-blind, fixed-dose, placebo-controlled trial with olanzapine as an active control.
    Landbloom R; Mackle M; Wu X; Kelly L; Snow-Adami L; McIntyre RS; Mathews M; Hundt C
    CNS Spectr; 2017 Aug; 22(4):333-341. PubMed ID: 27821210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term assessment of Asenapine vs. Olanzapine in patients with schizophrenia or schizoaffective disorder.
    Schoemaker J; Naber D; Vrijland P; Panagides J; Emsley R
    Pharmacopsychiatry; 2010 Jun; 43(4):138-46. PubMed ID: 20205074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asenapine for long-term treatment of bipolar disorder: a double-blind 40-week extension study.
    McIntyre RS; Cohen M; Zhao J; Alphs L; Macek TA; Panagides J
    J Affect Disord; 2010 Nov; 126(3):358-65. PubMed ID: 20537396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asenapine versus olanzapine in acute mania: a double-blind extension study.
    McIntyre RS; Cohen M; Zhao J; Alphs L; Macek TA; Panagides J
    Bipolar Disord; 2009 Dec; 11(8):815-26. PubMed ID: 19832806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials.
    Szegedi A; Zhao J; van Willigenburg A; Nations KR; Mackle M; Panagides J
    BMC Psychiatry; 2011 Jun; 11():101. PubMed ID: 21689438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy from an 8 Week Double-Blind Trial and a 26 Week Open-Label Extension of Asenapine in Adolescents with Schizophrenia.
    Findling RL; Landbloom RP; Mackle M; Pallozzi W; Braat S; Hundt C; Wamboldt MZ; Mathews M
    J Child Adolesc Psychopharmacol; 2015 Jun; 25(5):384-96. PubMed ID: 26091193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Tolerability of Asenapine Compared with Olanzapine in Borderline Personality Disorder: An Open-Label Randomized Controlled Trial.
    Bozzatello P; Rocca P; Uscinska M; Bellino S
    CNS Drugs; 2017 Sep; 31(9):809-819. PubMed ID: 28741044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lurasidone in the treatment of schizophrenia: a randomized, double-blind, placebo- and olanzapine-controlled study.
    Meltzer HY; Cucchiaro J; Silva R; Ogasa M; Phillips D; Xu J; Kalali AH; Schweizer E; Pikalov A; Loebel A
    Am J Psychiatry; 2011 Sep; 168(9):957-67. PubMed ID: 21676992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.
    Lindenmayer JP; Khan A; Iskander A; Abad MT; Parker B
    J Clin Psychiatry; 2007 Mar; 68(3):368-79. PubMed ID: 17388705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asenapine: a review of its use in the management of mania in adults with bipolar I disorder.
    Chwieduk CM; Scott LJ
    CNS Drugs; 2011 Mar; 25(3):251-67. PubMed ID: 21323396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
    McIntyre RS; Cohen M; Zhao J; Alphs L; Macek TA; Panagides J
    J Affect Disord; 2010 Apr; 122(1-2):27-38. PubMed ID: 20096936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states.
    McIntyre RS; Cohen M; Zhao J; Alphs L; Macek TA; Panagides J
    Bipolar Disord; 2009 Nov; 11(7):673-86. PubMed ID: 19839993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy and safety of asenapine or olanzapine in patients with schizophrenia or schizoaffective disorder: an extension study.
    Schoemaker J; Stet L; Vrijland P; Naber D; Panagides J; Emsley R
    Pharmacopsychiatry; 2012 Jul; 45(5):196-203. PubMed ID: 22454251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine vs risperidone in the management of schizophrenia: a randomized double-blind trial in Australia and New Zealand.
    Gureje O; Miles W; Keks N; Grainger D; Lambert T; McGrath J; Tran P; Catts S; Fraser A; Hustig H; Andersen S; Crawford AM
    Schizophr Res; 2003 Jun; 61(2-3):303-14. PubMed ID: 12729882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.
    Lindenmayer JP; Czobor P; Volavka J; Lieberman JA; Citrome L; Sheitman B; Chakos M; McEvoy JP
    J Clin Psychiatry; 2002 Oct; 63(10):931-5. PubMed ID: 12416603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.